![](/img/cover-not-exists.png)
Phase I clinical study of brentuximab vedotin (SGN-35) involving children with recurrent or refractory CD30-positive Hodgkin’s lymphoma or systemic anaplastic large cell lymphoma: rationale, design and methods of BV-HLALCL study: study protocol
Sekimizu, Masahiro, Iguchi, Akihiro, Mori, Tetsuya, Koga, Yuhki, Kada, Akiko, Saito, Akiko M., Horibe, KeizoVolume:
18
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-018-4042-1
Date:
December, 2018
File:
PDF, 402 KB
english, 2018